Tag: biotechnology
-
Species Restoration Company Raises $60M in New Funds
A biotechnology start-up aiming to restore extinct animal species with gene editing is raising $60 million in its first venture funding round.
-
Start-Up Designs RNA Drugs on Demand, Raises $40M
A new company is applying artificial intelligence and other computational techniques to quickly design and discover RNA components for precision therapies.
-
Biotech Converting CO2 to Food Components Raises $7M
A start-up company creating a process to convert carbon dioxide into food protein elements with microorganisms is raising $7 million in seed funds.
-
Covid-19 Nasal Vaccine Produces Antibodies, Cuts Viral Load
Tests with lab animals show a vaccine given as a nasal spray produces high antibody volumes against SARS-CoV-2 infections and reduces viral loads.
-
Patent Board Rules for Broad Inst. in Crispr Case
A U.S. patent appeals board ruled that the Broad Institute at Harvard and MIT is the discoverer of Crispr gene editing techniques in animal cells.
-
Clinical Trial Set for AI-Driven Lung Fibrosis Drug
A clinical trial is set to begin testing the safety and chemical activity of a drug candidate for lung fibrosis, discovered and refined with artificial intelligence.
-
Digital Neuroscience Companies Partner on AR/AI Diagnostics
Two companies creating digital technologies for neurological conditions are collaborating on augmented reality and artificial intelligence in diagnostics.
-
Precision Meds Continue Gaining FDA Approvals
Food and Drug Administration approved 17 new medications in 2021 addressing genetic targets, according to data from a precision medicine advocacy group.
-
New Industry, Academic Studies Arrive at Space Station
Several experiments from companies and academic labs arrived today at the International Space Station to test effects of microgravity and other conditions.
-
ALS Therapy Start-Up Gains $5.1M in Seed Funds
A start-up enterprise is developing a treatment for amyotrophic lateral sclerosis or ALS, spun off from university research labs and an ALS advocacy group.